Stay updated on PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page.
Latest updates to the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.3%
- Check24 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check53 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check60 days agoChange DetectedThe website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check74 days agoChange DetectedNo new additions were noted, but a significant section of content related to downloading data formats and selecting study fields has been removed.SummaryDifference13%
Stay in the know with updates to PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page.